Gladstone Institutional Advisory’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,709
Closed -$92K 698
2021
Q4
$92K Buy
1,709
+42
+3% +$2.83K 0.01% 583
2021
Q3
$115K Buy
+1,667
New +$118K 0.01% 523
2019
Q4
Sell
-112
Closed -$59K 274
2019
Q3
$59K Buy
112
+7
+7% +$5.19K 0.02% 275
2019
Q2
$99K Buy
105
+9
+9% +$9.04K 0.03% 263
2019
Q1
$105K Buy
96
+6
+7% +$5.37K 0.04% 208
2018
Q4
$54K Buy
+90
New +$66.3K 0.03% 167

Other funds holding ACB

Gladstone Institutional Advisory's ACB Position: Q1 2022 in Review

Gladstone Institutional Advisory sold out of Aurora Cannabis (ACB) in Q1 2022, closing a stake of 1,709 shares — an estimated $92K sold.

Gladstone Institutional Advisory first reported a position in ACB in Q4 2018 and held it in 6 quarters. The position peaked at $115K in Q3 2021. 253 funds tracked by Wall St. Rank hold ACB as of Q1 2022.

  • Gladstone Institutional Advisory reported no remaining Aurora Cannabis position as of Q1 2022 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 1,709 Aurora Cannabis shares in Q1 2022, an estimated $92K.
  • Gladstone Institutional Advisory first reported a position in Aurora Cannabis in Q4 2018 and held it in 6 quarters.
  • Gladstone Institutional Advisory's Aurora Cannabis position peaked at $115K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2022.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2022, filed 4 May 2022.